Veradermics (MANE) Preferred Stock Liabilities (2024 - 2025)

Veradermics (MANE) has 2 years of Preferred Stock Liabilities data on file, last reported at $78.9 million in Q4 2025.

• Quarterly Preferred Stock Liabilities rose 114.06% year-over-year to $78.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $78.9 million (up 114.06% YoY) and the FY2025 annual result came in at $78.9 million, up 114.06% from the prior year.
• Preferred Stock Liabilities advanced to $78.9 million in Q4 2025, from $36.9 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $78.9 million in Q4 2025 to a low of $36.9 million in Q4 2024.